Pellegrini Hospital, Naples, Italy.
Buon Consiglio Fatebenefratelli Hospital, Division of Cardiology, Naples, Italy.
Pacing Clin Electrophysiol. 2022 May;45(5):612-618. doi: 10.1111/pace.14482. Epub 2022 Apr 22.
Although radiofrequency (RF) catheter ablation of cavo-tricuspid isthmus (CTI) is an established treatment for typical right atrial flutter (RAFL), it remains to be established whether local tissue impedance (LI) is able to predict effective CTI ablation and what LI drop values during ablation should be used to judge a lesion as effective. We aimed to investigate the ability of LI to predict ablation efficacy in patients with RAFL.
RF delivery was guided by the DirectSense™ algorithm. Successful single RF application was defined according to a defragmentation of atrial potentials (DAP), reduction of voltage (RedV) by at least 80% or changes on unipolar electrogram (UPC). The ablation endpoint was the creation of bidirectional conduction block (BDB) across the isthmus.
392 point-by-point RF applications were analyzed in 48 consecutive RAFL patients. The mean baseline LI was 105.4 ± 12Ω prior to ablation and 92.0 ± 11Ω after ablation (p < 0.0001). According to validation criteria, absolute drops in impedance were larger at successful ablation sites than at ineffective ablation sites (DAP: 17.8 ± 6Ω vs. 8.7 ± 4Ω; RedV: 17.2 ± 6Ω vs. 7.8 ± 5Ω; UPC: 19.6 ± 6Ω vs. 10.1 ± 5Ω, all p < 0.0001). LI drop values significantly increased according to the number of criteria satisfied (ranging from 7.5Ω to 19.9). BDB was obtained in all cases. No procedure-related adverse events were reported.
A LI-guided approach to CTI ablation was safe and effective in treating RAFL. The magnitude of LI drop was associated with effective lesion formation and BDB and could be used as a marker of ablation efficacy.
Catheter Ablation of Arrhythmias with a High-Density Mapping System in Real-World Practice (CHARISMA). URL: http://clinicaltrials.gov/ Identifier: NCT03793998.
尽管射频(RF)导管消融腔静脉-三尖瓣峡部(CTI)是治疗典型右房扑动(RAFL)的一种既定方法,但仍需要确定局部组织阻抗(LI)是否能够预测有效的 CTI 消融,以及消融过程中应使用何种 LI 下降值来判断病变是否有效。我们旨在研究 LI 在 RAFL 患者中的预测消融效果的能力。
采用 DirectSense™算法指导 RF 输送。根据心房电位碎裂(DAP)、电压降低(RedV)至少 80%或单极电图(UPC)的变化来定义单次 RF 应用的成功。消融终点是峡部双向传导阻滞(BDB)的建立。
对 48 例连续的 RAFL 患者的 392 个逐点 RF 应用进行了分析。消融前的平均基线 LI 为 105.4±12Ω,消融后的 LI 为 92.0±11Ω(p<0.0001)。根据验证标准,在成功消融部位的阻抗绝对下降大于在无效消融部位的阻抗绝对下降(DAP:17.8±6Ω vs. 8.7±4Ω;RedV:17.2±6Ω vs. 7.8±5Ω;UPC:19.6±6Ω vs. 10.1±5Ω,均 p<0.0001)。随着满足标准数量的增加,LI 下降值显著增加(范围为 7.5Ω至 19.9Ω)。所有病例均获得 BDB。未报告与操作相关的不良事件。
LI 指导的 CTI 消融方法在治疗 RAFL 方面是安全有效的。LI 下降幅度与有效病变形成和 BDB 相关,可作为消融效果的标志物。
高密度标测系统在真实世界实践中的心律失常导管消融(CHARISMA)。网址:http://clinicaltrials.gov/ 标识符:NCT03793998。